DO YOU KNOW THE EXCLUSIVE CONSORTIUM OF LAB4® STRAINS PRESENT IN OUR LINE OF PROBIOTICS?

Our line of Probiotics is made up of an exclusive and powerful combination of specific bacterial strains from the Lab4® consortium. Specially designed to resist stomach and bile acids, reflecting a HEALTHY intestine in newborns, infants and adults. The Lab4® consortium restores the intestinal microbiota by repopulating it with the ideal commensal bacteria suitable for each age group.

It consists of a combination of patented bacteria, which has been used in various probiotic brands around the world, benefiting thousands of people. These strains have been isolated from the microbiota of healthy humans, scientifically demonstrating action in restoring intestinal function, being safe to consume.

The Lab4® consortium combines four strains of bacteria: two strains of Lactobacillus acidophilus, one Bifidobacterium animalis subsp. lactis and Bifidobacterium bifidum, which have been isolated from the intestinal microbiota of healthy humans and then examined for suitable probiotic characteristics, ranging from resistance to stomach and bile acids, to a robust ability to be cultured and commercialized in vitro on a large scale.

The Lab4B® consortium has been specifically designed to reflect the gut of newborn babies and breastfed infants. It also combines four strains of bacteria. It contains the same Bifidobacterium animalis subsp. lactis and Bifidobacterium bifidum present in the Lab4® consortium, but it is specifically combined with Lactobacillus salivarius and Lactobacillus paracasei instead of the two strains of Lactobacillus acidophilus.

Since their creation, the Lab4® and Lab4B® consortia have been the subject of various clinical trials in humans and scientific research. Most of this work has been published and is available at www.lab4probiotics.co.uk

These investigations have been developed based on more than 30 years of experience and research in the Probiotics industry, which has been carried out in collaboration with the best hospitals, universities and research institutions in the United Kingdom and Europe. .

Lab4® probiotics to date have undergone 22 probiotic clinical trials supported by ongoing in vitro and in vivo studies. These studies cover a wide range of conditions, including irritable bowel syndrome, immunity, allergies, sports performance, cognitive function, and antibiotic use.

Next, we will review the conclusions obtained from the various studies carried out with Lab4® and Lab4B® at different powers in Billions.

12.5 Billion Lab4®

Reduces coughs and colds

https://lab4probiotics.co.uk/our-research/lab-4-studies/pro-child-study

“ Lab4® probiotics in combination with vitamin C significantly reduced the incidence and duration of both coughs and colds and school absenteeism”

25 Billion Lab4®

Reduces antibiotic resistance in adults

https://lab4probiotics.co.uk/our-research/lab-4-studies/the-cambridge-probiotic-antibiotic-trial-1

“Supplementation with Lab4® probiotics in parallel to antibiotic therapy has been shown to reduce the overgrowth of undesirable and potentially harmful bacteria both during and after therapy”

Reduces antibiotic-associated diarrhea in adults

https://lab4probiotics.co.uk/our-research/lab-4-studies/the-cambridge-clos-dif-study

“Supplementation with Lab4® probiotics may reduce the incidence of C. difficile diarrhea in hospitalized patients.

Improves Immune Function

https://lab4probiotics.co.uk/our-research/lab-4-studies/adult-immune-response-study

“The consumption of Lab4® probiotics in combination with FOS (Prebiotic Fiber) modulates the production of cytokines, which demonstrates the possible immunomodulatory benefits”

Reduces IBS symptoms

https://lab4probiotics.co.uk/our-research/lab-4-studies/sheffield-ibs-study

“ Lab4® probiotics significantly reduced symptoms and improved quality of life in patients diagnosed with IBS (Irritable Bowel Syndrome). “Continuous supplementation was considered necessary to maintain this improvement”

Improves athletic performance

https://lab4probiotics.co.uk/our-research

“Supplementation with Lab4® probiotics improved the runners' finishing time during the marathon”

30 Billion Lab4®

Reduced intestinal permeability in athletes

https://lab4probiotics.co.uk/our-research/lab-4-studies/hertfordshire-study

“ Lab4® probiotics with fiber alone or in combination with antioxidants protect athletes from intestinal alterations during resistance training and improve their race finishing times”

50 Billion Lab4®

Improved cognitive function

https://lab4probiotics.co.uk/our-research/lab-4-studies/the-keele-study

“The study showed the benefit of Lab4® probiotics for cognitive function in healthy individuals”

Anxiety reduction

https://lab4probiotics.co.uk/our-research/lab-4-studies/the-keele-study

“The study showed the benefit of Lab4® probiotics for cognitive function in healthy individuals”

10 Billion Lab4B®

The Swansea baby study

https://lab4probiotics.co.uk/our-research/lab4-b-studies/swansea-baby-trial

“Senior author Professor Steve Allen concluded with the following key message from the trial: “Lactobacilli and bifidobacteria administered to pregnant women and infants aged 0 to 6 months prevented atopic sensitization and atopic eczema.”

“Prevention of allergies”

“Reduction of constipation”

Valeria Riquelme

Nutritionist

If you have additional questions, you can write to us directly at nutricion@biocarechile.cl